Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,811 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Galician consensus on management of cardiotoxicity in breast cancer: risk factors, prevention, and early intervention.
Cueva JF, Antolín S, Calvo L, Fernández I, Ramos M, de Paz L, Mata JG, López R, Constenla M, Pérez E, González A, Pellón ML, Varela S, López T. Cueva JF, et al. Among authors: perez e. Clin Transl Oncol. 2017 Sep;19(9):1067-1078. doi: 10.1007/s12094-017-1648-8. Epub 2017 Mar 24. Clin Transl Oncol. 2017. PMID: 28342058 Free PMC article.
Is there a correlation between HER2 gene amplification level and response to neoadjuvant treatment with trastuzumab and chemotherapy in HER2-positive breast cancer?
Antolín S, García-Caballero L, Reboredo C, Molina A, Mosquera J, Vázquez-Boquete Á, Gallego R, Santiago MP, Concha Á, Pérez E, Calvo L, García-Caballero T. Antolín S, et al. Among authors: perez e. Virchows Arch. 2021 Oct;479(4):853-857. doi: 10.1007/s00428-021-03104-7. Epub 2021 May 1. Virchows Arch. 2021. PMID: 33934230 Review.
Correction to: Is there a correlation between HER2 gene amplification level and response to neoadjuvant treatment with trastuzumab and chemotherapy in HER2‑positive breast cancer?
Antolín S, García-Caballero L, Reboredo C, Molina A, Mosquera J, Vázquez-Boquete Á, Gallego R, Santiago MP, Concha Á, Pérez E, Calvo L, García-Caballero T. Antolín S, et al. Among authors: perez e. Virchows Arch. 2021 Oct;479(4):859. doi: 10.1007/s00428-021-03121-6. Virchows Arch. 2021. PMID: 34117906 No abstract available.
Angiogenic factors versus fetomaternal Doppler for fetal growth restriction at term: an open-label, randomized controlled trial.
Garcia-Manau P, Bonacina E, Martin-Alonso R, Martin L, Palacios A, Sanchez-Camps ML, Lesmes C, Hurtado I, Perez E, Tubau A, Ibañez P, Alcoz M, Valiño N, Moreno E, Borrero C, Garcia E, Lopez-Quesada E, Diaz S, Broullon JR, Teixidor M, Chulilla C, Ferrer-Costa R, Gil MM, Lopez M, Ramos-Forner GM, Blanco JE, Moreno A, Lázaro-Rodríguez M, Vaquerizo O, Soriano B, Fabre M, Gomez-Valencia E, Cuiña A, Alayon N, Sainz-Bueno JA, Vives A, Esteve E, Ocaña V, López MÁ, Maroto A, Carreras E, Mendoza M. Garcia-Manau P, et al. Among authors: perez e. Nat Med. 2025 Jan 7. doi: 10.1038/s41591-024-03421-9. Online ahead of print. Nat Med. 2025. PMID: 39775039
The impact of hypoalbuminemia on the long-term prognosis of patients with acute heart failure: The modifying role of carbohydrate antigen 125.
Llàcer P, Croset F, de la Espriella R, García M, Miñana G, Campos J, Santas E, Pérez C, Lorenzo M, Pérez A, Núñez G, Pérez E, Manzano L, Núñez J. Llàcer P, et al. Among authors: perez e. Eur J Intern Med. 2025 Jan 2:S0953-6205(24)00528-4. doi: 10.1016/j.ejim.2024.12.024. Online ahead of print. Eur J Intern Med. 2025. PMID: 39753436
2,811 results